Xpert C. difficile/Epi

Identify. Differentiate. Prevent.

The epidemic strain of Clostridium difficile (027/NAP1/BI) is known to produce a significantly higher number of C. difficile spores and toxins. The epidemic strain has also been identified as a cause of hospital outbreaks worldwide. Healthcare professionals can now be informed on the epidemic C. difficile strain and make appropriate infection control decisions.

Xpert^®C. difficile/Epi — Identify. Differentiate. Prevent.

Runs On: GeneXpert^® System

The Need

Numerous outbreaks caused by the epidemic strain of C. difficile (027/NAP1/BI strain) highlight the need for rapid and accurate differentiation of C.difficile 027/NAP1/BI strains in order to stay ahead of an outbreak.

• Higher risk of cross contamination with 027/NAP1/BI strain due to more efficient sporulation
• 027/NAP1/BI strain has been identified as a cause of outbreaks around the world
• Incremental costs due to C. difficile infection can be as high as $7,179 per patient
   

The Solution

Xpert C. difficile/Epi is the first commercially available test in the world to detect and differentiate the epidemic strain of C. difficile (027/NAP1/BI). With rapid and accurate identification of epidemic strain, Infection Control professional can stay ahead of potential outbreak situation.

• Innovative multiplex design enables detection of C. difficile Infection (CDI) and 027/NAP1/BI strain call-out in a single cartridge
• On-Demand testing of samples from suspected CDI patients provides On-Demand epidemiological surveillance data clinicians can act on
• Monitoring and reporting of the epidemic strain enables clinicians to improve infection control efforts

Cepheid's Xpert C. difficile/Epi test provides on-demand results you can trust and empowers your clinical team to better manage patients.